Pre-Filled Syringes Americas: development, manufacture and regulation news for pre-filled syringes and injector devices

Share Article

Industry Leaders will meet in Iselin, New Jersey, USA to discuss current and emerging trends within the industry.

Pre-Filled Syringes America

Pre-Filled Syringes America

A wise choice of location and an intelligently designed program of expert speakers promises to bring together the leading influencers mapping the future of the prefilled syringes sector. --Guy Furness, Proprietor & Publisher, ONdrugDelivery Magazine

The importance of pre-filled syringes and injection devices have never been more pertinent, especially in the US. The challenges of finding a delivery method with patient centric design that avoids leaching, requires swift and decisive decisions early in the development process to avoid unnecessary costs and delays in development.

The SMi Group announces its Pre-Filled Syringes Americas Conference will be taking place in Iselin, New Jersey, USA, on the 31st March – 1st April 2014, where solutions to these challenges will be offered by many of the leading names in pharmaceuticals and medical device technologies.

Event’s website: http://www.smi-online.co.uk/2014pfs-usa53.asp

Registration is now open. Over 85 delegates from the world’s leading Pharmaceutical and Biotechnology businesses will meet in New Jersey to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.

Some of leading figures in injection technology speaking at the event include Scott Brown, Device Development Lead, Merck; Joern Koehler, Deputy Head of Liquid Vials & Prefilled Syringes, Roche; Alexei Goraltchouk, Senior Manager, Operations Regeneron; Stephen Barat, Senior Director, Toxicology and Operations, Forest Laboratories; Steven Projan, SVP, MedImmune; Martin Dearden, Chief Corporate Microbiologist, UCB; Thomas Osterberg, Senior Manager, Biologics, Pfizer Inc; Greg Sacha, Senior Research Scientist, Baxter and many others.

There will be a panel discussion, “Developing delivery systems for biological products” hosted by Cliff Mintz, Senior Writer/Correspondent, Life Science Leader; William Lambert, Drug Delivery and Device Development, Medimmune Inc; Martin Dearden, Corporate Microbiologist, UCB and Thomas Osterberg, Senior Manager, Biologics, Pfizer.

Interactive half-day post-conference workshop "Accelerating the regulatory approval of your pre-filled product: Insight into combination product approvals", hosted by Ravi S. Harapanhalli, Vice President, PAREXEL, and Former FDA Senior Executive, and Mr. Sall, Principal Consultant, PAREXEL, will take place on the 2nd of April 2014.

Early bird deadline for registrations, to save $100, expires on Friday, 31st of January.

For more information about the conference, on to register, visit the event’s website: http://www.smi-online.co.uk/2014pfs-usa53.asp

Alternatively, contact Fateja Begum on +44 (0) 207 827 1184 or fbegum(at)smi-online(dot)co(dot)uk.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sonal Patel

Sonal Patel
SMi Group Ltd
+44-207-827-6106
Email >
Visit website